P3 Health Partners Inc
NASDAQ:PIII
P3 Health Partners Inc
NASDAQ:PIII
Price:
0.578 USD
7.59%
Updated:
May 2, 2024
P3 Health Partners Inc
Cash from Financing Activities
|
P3 Health Partners Inc
Cash from Financing Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
P3 Health Partners Inc
NASDAQ:PIII
|
Cash from Financing Activities
$100.3m
|
CAGR 3-Years
42%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
$2.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$4.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is P3 Health Partners Inc's Cash from Financing Activities?
Cash from Financing Activities
100.3m
USD
100.3m
USD
Based on the financial report for Dec 31, 2023, P3 Health Partners Inc's Cash from Financing Activities amounts to 100.3m USD.
What is P3 Health Partners Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
25%
25%
Over the last year, the Cash from Financing Activities growth was 782%. The average annual Cash from Financing Activities growth rates for P3 Health Partners Inc have been 42% over the past three years , 25% over the past five years .
You don't have any saved screeners yet
